An in-depth look to DAEWOONG PHARMACEUTICAL operating, investing, and financing activities

069620 free cash flow for Q2 24 is -47.72 B KRW. For 2023, 069620 free cash flow was 21.67 B KRW and operating cash flow was 131.01 B KRW.